Brief: Organogenesis Holdings Inc. Reports Third Quarter 2022 Financial Results
09/11/2022 22:20
Organogenesis Holdings Inc ORGO.O :
* ORGANOGENESIS HOLDINGS INC Q3 REVENUE ROSE 3 PERCENT TO
$116.9
MILLION
* ORGANOGENESIS HOLDINGS INC. REPORTS THIRD QUARTER 2022
FINANCIAL
RESULTS
* ORGANOGENESIS HOLDINGS INC QTRLY EARNINGS PER SHARE $0.00
* ORGANOGENESIS HOLDINGS INC - FOR YEAR ENDING DECEMBER 31,
2022,
COMPANY EXPECTS NET REVENUE OF BETWEEN $448 MILLION AND $465
MILLION
Source text for Eikon: ID:nGNX9SHmjN
Further company coverage: ORGO.O
Recent news on Organogenesis Holdings
See all newsBrief: Organogenesis Announces Publication Of Peer-Reviewed Prepare Trial Results
Organogenesis Holdings Inc. reports results for the quarter ended June 30 - Earnings Summary
Brief: Organogenesis Q2 Net Product Revenue USD 42.8 Million
Organogenesis Holdings Inc. expected to post a loss of 35 cents a share - Earnings Preview
Brief: Organogenesis Announces Publication Of Peer-Reviewed Clinical Trial Results Demonstrating Clinical Benefit Of Affinity™ In The Most Challenging And Complex Venous Leg Ulcers